The global cell analysis market was valued at $16.5 billion in 2021 and it is expected to reach $48.3 billion at a CAGR of 10.1%between 2022 and 2032. Cell analysis is usually used for a large variety of technologies that are utilized to study the genetic and phenotypical characteristics of all kinds of cells. The primary objective of cell analysis is to gain insights into the mechanisms of cellular works that requires an understanding of the cellular components.
By region, North America has led the cell analysis market across the globe with a significant share.
Cell analysis is used to discover quality drugs in a short time when compared to traditional methods. It also studies the actual behavior of cells in multiple cellular organisms. Incidences of several chronic diseases are rising in past few years. Decreased immunity and more exposure to harmful environments are one of the major reasons for such types of ailments. Due to this many companies are looking for faster development of drugs which in turn increased demand for cell analysis. Chronic health issues or human structural disorders increment due to COVID are also likely to accelerate the market at a faster rate.
Source: SAI Research
Additionally, the geriatric population is rising in mostly all developed countries, and this is fueling the rate of cell analysis market growth. According to UN data, by 2019, around 9% of the world population was above 9% when compared to 6% a decade ago. In conjunction with this increment, multiple ailments and problems in the geriatric population lead to a new avenue for medical companies to grow. This growth in diseases will demand specialized medications as per the target group leading to the increasing demand for cell analysis tools and methods across the globe. Multiple companies are focusing on expanding their business growth by establishing new mergers and acquisitions with other manufacturing companies. Hence, this would benefit the market to grow for a certain period. Governments from several developed nations are investing in extensive research and development programs. This is another major contributor to the growth of the cell analysis market across the globe.
Based on product, the global cell analysis market is segmented into consumables, instruments, flow cytometers, cell counters, high content screening systems, cell microarrays, and others. The consumable product type holds the largest share of the market and is anticipated to lead the market with the highest revenue shares. Due to the increasing prevalence of the use of appropriate devices in laboratories as well as research and technology centers to evaluate better results, which are likely to fuel the demand. On the other hand, the instrument section is estimated to lead the market which is generated by money as a result of the installation of new instruments and the replacement of outdated ones.
Based on application type, the global cell analysis market is categorized into cell identification, cell viability, cell signaling pathway, cell counting, quality control, single-cell analysis, and others. The single-cell analysis segment is anticipated to hold the maximum share of the market throughout the forecast period. Along with this, the cell identification category is accounted for the maximum share of the market over the upcoming years due to its rising usage as it serves as an essential step in multiple industries and organizations including the food and medical sectors. Furthermore, this segment has gained significant traction over the last few years and is also expected to contribute to segment growth.
Based on end-user, the market is divided into medical sectors, contract research organizations, laboratories, and cell culture collection repositories, among others. Among these categories, the division of the medical sector is accounted for the largest market share over the upcoming years. The rising use of instruments and consumables at multiple drug discovery and development stages is expected to propel market growth. Adoption of highly complex and specialized assays is rising which is driving the market growth.
Geographically, the global cell analysis market is segmented into North America, Europe, Asia-Pacific, Latin America, and Africa. Among these regions, North America holds the largest share of the market and is expected to hold its dominant position over the forecast period. Most of the key players are located in this region which is a positive sign of market growth. Besides this, the environment for the business is very favorable, and key players are getting strong support from the government in several nations. Additionally, companies are well established. Therefore, these major factors are expected to boost the growth of the cell analysis market across the globe during the forecast period from 2022 to 2032.
According to the study, key players such as 10x Genomics (U.S), Agilent Technologies (U.S), BioStatus Limited (U.K), BICO (U.S), Bio-Rad Laboratories (U.S), Becton Dickinson (U.S), Corning Incorporated (U.S), Cell Biolabs (China), Creative Bioarray (U.S), Danaher Corporation (U.S), Fluidigm Corporation (U.S), General Electric (U.S), Merck Group (Germany), Meiji Techno (U.S), Miltenyi Biotec (Germany), NanoCollect Biomedical (U.S), Olympus Corporation (Japan), PerkinElmer (U.S), Promega Corporation (U.S), QIAGEN (Germany), Thermo Fisher Scientific (U.S), Tecan (Switzerland), among others are leading the global cell analysis market.
Scope of the Report:
|Market Size in 2021||US$ 16.5 Billion|
|Market Volume Projection by 2032||US$ 48.3 Billion|
|Forecast Period 2022 to 2032 CAGR||10.1%|
|Historical Data||2019, 2020 and 2021|
|Forecast Period||2022 to 2032|
By Product: Consumables Instruments, Flow Cytometers, Cell Counters, High Content Screening System, Cell Microarrays & Others
By Application Type: Cell Identification, Cell Viability, Cell Signaling Pathway, Cell Counting and Quality Control, Single-Cell Analysis & Others
By End-User: Medical Sectors, Contract Research Organizations, Laboratories, Cell Culture Collection Repositories & Others
North America, Europe , Asia-Pacific , LAMEA
|Companies covered||10x Genomics (U.S), Agilent Technologies (U.S), BioStatus Limited (U.K), BICO (U.S), Bio-Rad Laboratories (U.S), Becton Dickinson (U.S), Corning Incorporated (U.S), Cell Biolabs (China), Creative Bioarray (U.S), Danaher Corporation (U.S), Fluidigm Corporation (U.S), among others|
The Global Cell Analysis Market Has Been Segmented Into:
The Global Cell Analysis Market – by Product:
The Global Cell Analysis Market – by Application Type:
The Global Cell Analysis Market – by End-User:
The Global Cell Analysis Market – by Regions: